Haleon Plc current report, Q2 FY2024

Haleon plc Form 6-K Summary

Business context and reporting period

Haleon plc filed this Form 6-K for April 2024. The filing announces the publication of materials for the company’s 2024 Annual General Meeting and does not report quarterly or annual financial results.

Haleon is a global consumer-health company operating across oral health, pain relief, respiratory health, digestive health, vitamins, minerals and supplements, and other consumer-health categories. Its brands include Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum.

Financial and operating metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial performance metrics.

Material changes versus the prior comparable period

No financial or operating changes versus a prior comparable period are disclosed. The principal update is the release of the 2024 AGM documentation.

Governance, outlook, risks and unusual items

  • The 2024 AGM will be held virtually at 3:00 p.m. BST on Wednesday, 8 May 2024, broadcast from Haleon’s London offices under studio conditions.
  • Documents made available to shareholders include the Notice of AGM, the Form of Proxy, and the AGM Voting Instruction Card.
  • The Notice includes the full business agenda and meeting-joining instructions.
  • In compliance with UK Listing Rule 9.6.1, the documents were submitted to the National Storage Mechanism and were expected to become available for inspection there.
  • The filing contains no new business outlook, risk disclosures, contingencies, or unusual financial items.

Key facts for investors to verify

  • Review the full AGM Notice for proposed resolutions, director matters, remuneration-related votes, and other shareholder business.
  • Confirm the virtual-meeting access requirements and voting deadlines in the AGM materials.
  • Check the National Storage Mechanism and Haleon’s investor-relations website for the filed documents.
  • Consult Haleon’s separate results filings for financial performance, leverage, liquidity, guidance, and risk information.